Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Tandem Diabetes Care Inc shares valued at $258,400 were sold by Allen Dick on May 30 ’24. At $51.68 per share, Allen Dick sold 5,000 shares. The insider’s holdings dropped to 0 shares worth approximately $0.0 following the completion of this transaction.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Also, Allen Dick purchased 5,000 shares, netting a total of over 94,778 in proceeds. Following the buying of shares at $18.96 each, the insider now holds 19,962 shares.
Before that, Vosseller Leigh had added 6,200 shares to its account. In a trade valued at $95,395, the EVP & CHIEF FINANCIAL OFFICER bought Tandem Diabetes Care Inc shares for $15.39 each. Upon closing the transaction, the insider’s holdings increased to 6,200 shares, worth approximately $0.44 million.
As published in their initiating research note from Goldman on October 04, 2024, Tandem Diabetes Care Inc [TNDM] has been a Neutral and the price target has been revised to $46. Analysts at RBC Capital Mkts started covering the stock with ‘”an Outperform”‘ outlook in a report released in early October. As of August 22, 2024, Morgan Stanley has initiated its “an Equal-weight” rating for TNDM. Earlier on August 08, 2024, Canaccord Genuity initiated its rating. Their recommendation was “a Buy” for TNDM stock.
Analyzing TNDM Stock Performance
During the last five days, there has been a drop of approximately -4.14%. Over the course of the year, Tandem Diabetes Care Inc shares have jumped approximately 26.77%. Shares of the company reached a 52-week high of $53.69 on 05/31/24 and a 52-week low of $21.85 on 01/31/24. A 50-day SMA is recorded $41.93, while a 200-day SMA reached $37.24. Nevertheless, trading volume fell to 0.74 million shares from 0.88 million shares the previous day.
Support And Resistance Levels for Tandem Diabetes Care Inc (TNDM)
According to the 24-hour chart, there is a support level at 37.21, which, if violated, would cause prices to drop to 36.91. In the upper region, resistance lies at 37.90. The next price resistance is at 38.29. RSI (Relative Strength Index) is 36.02 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -2.21, which suggests the price will decrease in the coming days. Percent R is at 76.88%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
